Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HRUBY, Dennis")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 53

  • Page / 3
Export

Selection :

  • and

A trans-golgi network resident protein, golgin-97, accumulates in viral factories and incorporates into virions during poxvirus infectionALZHANOVA, Dina; HRUBY, Dennis E.Journal of virology. 2006, Vol 80, Num 23, pp 11520-11527, issn 0022-538X, 8 p.Article

Viral proteinases : Targets of opportunityBYRD, Chelsea M; HRUBY, Dennis E.Drug development research. 2006, Vol 67, Num 6, pp 501-510, issn 0272-4391, 10 p.Article

Conditional expression of vaccinia virus genes in mammalian cell lines expressing the tetracycline repressorHEDENGREN-OLCOTT, Marika; HRUBY, Dennis E.Journal of virological methods. 2004, Vol 120, Num 1, pp 9-12, issn 0166-0934, 4 p.Article

Discovery and development of antiviral drugs for biodefense : Experience of a small biotechnology companyBOLKEN, Tove C; HRUBY, Dennis E.Antiviral research. 2008, Vol 77, Num 1, pp 1-5, issn 0166-3542, 5 p.Article

Deletion of the vaccinia virus F13L gene results in a highly attenuated virus that mounts a protective immune response against subsequent vaccinia virus challengeVLIEGEN, Inge; YANG, Guang; HRUBY, Dennis et al.Antiviral research. 2012, Vol 93, Num 1, pp 160-166, issn 0166-3542, 7 p.Article

BiZyme: A novel fusion protein-mediating selection of vaccinia virus recombinants by fluorescence and antibiotic resistanceHANSEN, Scott G; COPE, Torrey A; HRUBY, Dennis E et al.BioTechniques. 2002, Vol 32, Num 5, pp 1178-1187, issn 0736-6205, 8 p.Article

The vaccinia virus F13L YPPL motif is required for efficient release of extracellular enveloped virusHONEYCHURCH, Kady M; GUANG YANG; JORDAN, Robert et al.Journal of virology. 2007, Vol 81, Num 13, pp 7310-7315, issn 0022-538X, 6 p.Article

Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - An animal model of smallpoxPARKER, Scott; CHEN, Nanhai G; SAGARTZ, John E et al.Antiviral research. 2012, Vol 94, Num 1, pp 44-53, issn 0166-3542, 10 p.Article

Severe Eczema Vaccinatum in a Household Contact of a Smallpox VaccineeVORA, Surabhi; DAMON, Inger; COLLINS, Limone et al.Clinical infectious diseases. 2008, Vol 46, Num 10, pp 1555-1561, issn 1058-4838, 7 p.Article

N -(3,3a,4,4a,5,5a,6,6a -Octahydro -1,3 -dioxo -4,6-ethenocycloprop[f]isoindol -2 -(1H) -yl )carboxamides : Identification of Novel Orthopoxvirus Egress InhibitorsBAILEY, Thomas R; RIPPIN, Susan R; KERN, Earl R et al.Journal of medicinal chemistry (Print). 2007, Vol 50, Num 7, pp 1442-1444, issn 0022-2623, 3 p.Article

An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challengeGUANG YANG; PEVEAR, Daniel C; HUGGINS, John W et al.Journal of virology. 2005, Vol 79, Num 20, pp 13139-13149, issn 0022-538X, 11 p.Article

Nonhuman Primates Are Protected from Smallpox Virus or Monkeypox Virus Challenges by the Antiviral Drug ST-246HUGGINS, John; GOFF, Arthur; KAREM, Kevin et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 6, pp 2620-2625, issn 0066-4804, 6 p.Article

The vaccinia virus G1L putative metalloproteinase is essential for viral replication in vivoHEDENGREN-OLCOTT, Marika; BYRD, Chelsea M; WATSON, Jeffrey et al.Journal of virology. 2004, Vol 78, Num 18, pp 9947-9953, issn 0022-538X, 7 p.Article

Commensal bacteria as a novel delivery system for subunit vaccines directed against agents of bioterrorismWILSON, Rebecca L; HRUBY, Dennis E.Advanced drug delivery reviews. 2005, Vol 57, Num 9, pp 1392-1402, issn 0169-409X, 11 p.Article

Comparison of transformation protocols in Streptococcus gordonii and evaluation of native promoter strength using a multiple-copy plasmidWARREN, Travis K; AMANDA LUND, S; JONES, Kevin F et al.Canadian journal of microbiology. 2007, Vol 53, Num 3, pp 417-426, issn 0008-4166, 10 p.Article

Identification of an intragenic integration site for foreign gene expression in recombinant Streptococcus gordonii strainsBOLKEN, Tove C; FRANKE, Christine A; ZELLER, Gloria O et al.Applied microbiology and biotechnology. 2001, Vol 55, Num 2, pp 192-197, issn 0175-7598Article

Oral immunization with recombinant Streptococcus gordonii expressing Porphyromonas gingivalis FimA domainsSHARMA, Ashu; HONMA, Kiyonobu; EVANS, Richard T et al.Infection and immunity. 2001, Vol 69, Num 5, pp 2928-2934, issn 0019-9567Article

The Broad-Spectrum Antiviral Compound ST-669 Restricts Chlamydial Inclusion Development and Bacterial Growth and Localizes to Host Cell Lipid Droplets within Treated CellsSANDOZ, Kelsi M; VALIANT, William G; ERIKSEN, Steven G et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 7, pp 3860-3866, issn 0066-4804, 7 p.Article

Identification of a Broad-Spectrum Arenavirus Entry InhibitorLARSON, Ryan A; DONGCHENG DAI; HOSACK, Virginia T et al.Journal of virology. 2008, Vol 82, Num 21, pp 10768-10775, issn 0022-538X, 8 p.Article

ST-246 Inhibits In Vivo Poxvirus Dissemination, Virus Shedding, and Systemic Disease ManifestationBERHANU, Aklile; KING, David S; MOSIER, Stacie et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 12, pp 4999-5009, issn 0066-4804, 11 p.Article

Conserved DegP protease in gram-positive bacteria is essential for thermal and oxidative tolerance and full virulence in Streptococcus pyogenesHAL JONES, C; BOLKEN, Tove' C; JONES, Kevin F et al.Infection and immunity. 2001, Vol 69, Num 9, pp 5538-5545, issn 0019-9567Article

Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in miceQUENELLE, Debra C; BULLER, R. M. L; PARKER, Scott et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 2, pp 689-695, issn 0066-4804, 7 p.Article

Impact of ST-246® on ACAM2000 smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient miceBERHANU, Aklile; KING, David S; MOSIER, Stacie et al.Vaccine. 2010, Vol 29, Num 2, pp 289-303, issn 0264-410X, 15 p.Article

Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit modelNALCA, Aysegul; HARKIN, Josh M; GARZA, Nicole L et al.Antiviral research. 2008, Vol 79, Num 2, pp 121-127, issn 0166-3542, 7 p.Article

In Vitro Efficacy of ST246 against Smallpox and MonkeypoxSMITH, Scott K; OLSON, Victoria A; KAREM, Kevin L et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 3, pp 1007-1012, issn 0066-4804, 6 p.Article

  • Page / 3